A Promising Recovery After a New Aortic Valve Procedure
A team of cardiologists in Michigan has implanted an artificial heart valve in a 76-year-old man by feeding the device through a vein in his left leg instead of opening his chest and stopping his heart.
Gadsden Times | Tuesday Mar 15
Edwards Testing Less-Invasive Valve
Irvine heart valve maker Edwards Lifesciences Corp. has entered a critical phase in the development of a product it sees playing a key role in future heart surgeries.
Orange County Business Journal | Tuesday Mar 15
Energy East elects two independent directors
Energy East Corp., which has its principal offices in Albany, N.Y., and Portland, Maine, announced on Monday that its board of directors had elected two new independent directors.
The Business Review | Jan 10, 2005
Edwards, St. Jude Medical settle heart valve patent suit
Heart-valve technology company Edwards Lifesciences Corp. said Friday it resolved a 2000 patent infringement suit with St.
Bizjournals.com | Jan 10, 2005
Crucell N.V. Announces PER.C6 Licensing Agreement With Edwards Lifes...
Dutch biotechnology company Crucell N.V. (Euronext:CRXL) ( Nasdaq :CRXL) announced today that it has signed a PER.C6(r) research license agreement with Edwards Lifesciences Corporation.
Biospace.com | Nov 24, 2004
PLC Systems to open clean room in Billerica
In February, PLC announced a partnership with Irvine, Calif.-based Edwards Lifesciences Corp.
Boston Business Journal | Oct 22, 2004
Durability & Fatigue Expert To Visit U.S. For Seminar Series
Safe Technology Ltd (United Kingdom), will be visiting the Dana Technical Resource Park, Ottawa Lake, Michigan (Nov 8th -12th 2004) and Edwards Lifesciences, Irvine, California (Dec 6th - 10th 2004), to present ...
Mcadcafe.com | Sep 2, 2004
Vascular Architects adds $11.6M in funding
All existing institutional investors participated in the financing round, the company says, including Foundation Medical Partners, Edwards Lifesciences LLC, Domain Associates, ARCH Venture Partners, Medtronic ...
San Jose Business Journal | Sep 2, 2004
Irvine, Calif., Firm's Artery Disease Therapy Starts Human Tests
Irvine's Edwards Lifesciences Corp. has begun human trials of a high-tech approach for treating peripheral arterial disease, a life-threatening ailment commonly known as hardening of the arteries.
Pharmacy Times | Sep 1, 2004
Today's Orange County business briefs
Edwards Lifesciences Corp. in Irvine announced Friday that it will receive 1 million from Baxter International Inc.
Ocregister.com | Jan 18, 2004
|
|
